Oh, well this is from the FDA label for Doxorubicin.
The average ORR for Bisantrene in R/R AML is actually 53%
Well, Bisantrene at 250 mg/m2 over 7-days has a 78% ORR in extramedullary AML, which is essentially solid tumor metastatic AML. A very difficult to treat cancer that many approved drugs have struggled.
Maybe Biotech just isn't for you?
Oh, well this is from the FDA label for Doxorubicin. The average...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.000(0.00%) |
Mkt cap ! $281.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 310 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 529 | 1 |
View Market Depth
| Last trade - 08.32am 08/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |
Day chart unavailable